Saltar al contenido
Merck
Todas las fotos(2)

Documentos

34219

Supelco

Temozolomida

VETRANAL®, analytical standard

Sinónimos:

3,4-Dihidro-3-metil-4-oxoimidazo[5,1-d]-1,2,3,5-tetracina-8-carboxamida, 3-Metil-4-oxo-8-imidazolo[5,1-d][1,2,3,5]tetracinecarboxamida, 4-Metil-5-oxo-2,3,4,6,8-pentazabiciclo[4.3.0]nona-2,7,9-trieni-9-carboxamida, 8-Carbamoil-3-metilimidazo[5,1-d]-1,2,3,5-tetracin-4(3H)-ona, NSC 362856

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

Fórmula empírica (notación de Hill):
C6H6N6O2
Número de CAS:
85622-93-1
Peso molecular:
194.15
MDL number:
MFCD00866492
UNSPSC Code:
41116107
PubChem Substance ID:
329754905
NACRES:
NA.24

grade

analytical standard

Quality Level

100

product line

VETRANAL®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

format

neat

storage temp.

2-8°C

SMILES string

CN1N=Nc2c(ncn2C1=O)C(N)=O

InChI

1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)

InChI key

BPEGJWRSRHCHSN-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

Temozolomide can be called as an oral alkylating agent and antitumour drug, which may show potent activity in the treatment of tumour like recurrent gliomas or glioblastoma.
Temozolomide can be called as an oral alkylating agent and antitumour drug, which may show potent activity in the treatment of recurrent gliomas or glioblastoma, a kind of tumour that affects the brain or spine.

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Health hazardExclamation mark
GHS08,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1B - Eye Irrit. 2 - Muta. 1B - Repr. 1B - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 3

ppe

Eyeshields, Gloves, type P2 (EN 143) respirator cartridges

Choose from one of the most recent versions:

Certificados de análisis (COA)

Lot/Batch Number
BCBZ8591
SZBF005XV
SZBC079XV
SZBA221XV
SZE8326X

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
Stupp R, et al.
Journal of Clinical Oncology, 20, 1375-1382 (2002)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
Hehi.EM, et al.
Clinical Cancer Research, 10(6), 1871-1874 (2004)
Glioma: Principles and Practice in Neuro-Oncology (2012)
NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA
Denny.JB, et al.
BioChemistry: An Indian Journal, 33(31), 9045-9051 (1994)
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
Stupp R, et al.
Journal of Clinical Oncology, 20(5), 1375-1382 (2002)
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico